Загрузка...
Combinational therapy of crizotinib and afatinib for malignant pleural mesothelioma
Malignant pleural mesothelioma (MPM) is a relative rare but highly aggressive neoplasm which is associated with asbestos exposure in most patients. The majority of patients are diagnosed in advanced stages so patients neither benefit from chemotherapy (e.g. pemetrexed-platinum combination) nor from...
Сохранить в:
| Опубликовано в: : | Am J Cancer Res |
|---|---|
| Главные авторы: | , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
e-Century Publishing Corporation
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5336496/ https://ncbi.nlm.nih.gov/pubmed/28337371 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|